SEC Filing Update: #TCRX TScan Therapeutics, Inc. : $0.79

Sector: Healthcare | YTD: 🔽 -23.30% The SEC disclosed Today (14-AUG-2026) that BIOTECHNOLOGY VALUE FUND L P has INCREASED #TCRX Shares by 21.06% 🟢 Lynx1 Capital Management LP also reported an increase in its holdings on the same day. * Previous Holdings: 3.01M Shares * Current Holdings: 3.65M Shares * Increase+634.74K * Increased(%)+21.06% * Ownership: 5.7% * Estimated Investment Value: $488.75K https://www.thinksabio.com/reports/isr/TCRX Institutional ownership in #TCRX has been steadily rising over the past 2 quarters in Shares: Q4 2025: 30.69M Q1 2026: 32.50M 📌 Institutional activity in the last 30 days for #TCRX: • Lynx1 Capital Management LP – Increased holdings by 12,500,000 shares (14-AUG-2026)